Top 50 Medical Device Startup Investors in United States (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Innova Memphis
VC Fund
|
74 | United States, Germany, Argentina | Seed, Pre-Seed, Convertible Note | Health Care, Medical, Medical Device | $25k–$1.6M |
|
Alumni Ventures
VC Fund
|
35 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $880k–$75M |
|
Portfolia
VC Fund
|
31 | United States, Canada, Germany | Seed, Series A, Series B | Health Care, Biotechnology, Software | $347k–$51M |
|
TEDCO
VC Fund
|
28 | United States, Canada, Colombia | Seed, Grant, Pre-Seed | Health Care, Software, Biotechnology | $25k–$2.5M |
|
Gaingels
VC Fund
|
25 | United States, Canada, Mexico | Seed, Series A, Series B | Software, Health Care, Artificial Intelligence | $1M–$100M |
|
Sand Hill Angels
VC Fund
|
25 | United States, Canada, India | Seed, Convertible Note, Series A | Software, Health Care, Biotechnology | $300k–$25M |
|
Right Side Capital Management
VC Fund
|
25 | United States, Canada, United Kingdom | Seed, Pre-Seed, Convertible Note | Software, SaaS, Health Care | $50k–$2M |
|
Launch NY
VC Fund
|
23 | United States, Canada, Denmark | Convertible Note, Seed, Pre-Seed | Software, Health Care, SaaS | $18k–$2.2M |
|
Khosla Ventures
VC Fund
|
23 | United States, India, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, Health Care | $2M–$100M |
|
Keiretsu Capital
VC Fund
|
23 | United States, Canada, India | Series A, Convertible Note, Seed | Health Care, Biotechnology, Medical | $50k–$12M |
|
Connecticut Innovations
VC Fund
|
22 | United States, Israel, Canada | Seed, Series A | Health Care, Biotechnology, Software | $150k–$25M |
|
CincyTech
VC Fund
|
22 | United States | Seed, Series A, Series B | Software, Health Care, Biotechnology | $250k–$20M |
|
TCA Venture Group
VC Fund
|
21 | United States, Canada | Seed, Convertible Note, Venture - Series Unknown | Health Care, Software, Biotechnology | $50k–$8.5M |
|
HealthTech Capital
VC Fund
|
21 | United States, Canada | Seed, Series A, Convertible Note | Health Care, Medical Device, Medical | $1M–$16M |
|
New York Angels
VC Fund
|
21 | United States, Israel, United Kingdom | Seed, Series A, Series B | Software, Health Care, Mobile | $365k–$15M |
|
SOSV
VC Fund
|
20 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Good Growth Capital
VC Fund
|
19 | United States, France, Israel | Seed, Series A, Convertible Note | Health Care, Biotechnology, Software | $25k–$24M |
|
Eniac Ventures
VC Fund
|
19 | United States, Canada, United Kingdom | Seed, Series A, Series B | Software, Information Technology, Mobile | $1.7M–$40M |
|
Texas HALO Fund
VC Fund
|
18 | United States, Canada, Hungary | Seed, Convertible Note, Series A | Health Care, Medical Device, Software | $105k–$10M |
|
Broadview Ventures
VC Fund
|
18 | United States, Switzerland, Canada | Series A, Seed, Series B | Health Care, Biotechnology, Medical Device | $1M–$45M |
|
Keiretsu Forum
VC Fund
|
17 | United States, India, Turkey | Seed, Series A | Health Care, Software, Biotechnology | $102k–$8.6M |
|
MB Venture Partners
VC Fund
|
16 | United States, Israel | Seed, Series B, Series C | Health Care, Medical, Medical Device | $50k–$28M |
|
Wavemaker 360
VC Fund
|
16 | United States, United Kingdom, Canada | Seed, Series A, Series B | Health Care, Medical, Artificial Intelligence | $100k–$30M |
|
North Coast Ventures
VC Fund
|
16 | United States | Series A, Seed | Health Care, Software, Medical Device | $500k–$14M |
|
Wisconsin Investment Partners
VC Fund
|
15 | United States, Canada, United Kingdom | Seed, Venture - Series Unknown | Health Care, Software, Biotechnology | $380k–$12M |
|
Oxford Finance LLC
VC Fund
|
15 | United States, United Kingdom, Canada | Debt Financing, Post-IPO Debt, Series B | Biotechnology, Health Care, Medical | $7.5M–$150M |
|
Arboretum Ventures
VC Fund
|
15 | United States, Canada, Israel | Series B, Series A, Series C | Health Care, Medical, Biotechnology | $4.4M–$80M |
|
Golden Seeds
VC Fund
|
15 | United States, Canada | Series A, Seed, Series B | Health Care, Software, Biotechnology | $740k–$20M |
|
Boston Harbor Angels
VC Fund
|
15 | United States, Canada, India | Angel, Seed, Series A | Health Care, Biotechnology, Medical Device | $100k–$6M |
|
Maine Angels
VC Fund
|
15 | United States | Seed, Series A | Health Care, Software, Biotechnology | $25k–$5.9M |
|
Rev1 Ventures
VC Fund
|
14 | United States, Germany | Seed, Series A | Software, Health Care, Information Technology | $200k–$18M |
|
Everywhere Ventures
VC Fund
|
14 | United States, Australia, India | Pre-Seed, Seed, Series A | Software, Health Care, FinTech | $250k–$20M |
|
Par Equity
VC Fund
|
14 | United Kingdom, United States, Brazil | Venture - Series Unknown, Seed | Software, Information Technology, Manufacturing | $168k–$4.3M |
|
StartUp Health
VC Fund
|
14 | United States, Canada, United Kingdom | Seed, Pre-Seed | Health Care, Wellness, Medical | $20k–$4M |
|
Red Cedar Ventures
VC Fund
|
14 | United States, The Netherlands, Canada | Pre-Seed, Seed, Series A | Software, Health Care, Medical | $20k–$50M |
|
U.S. Venture Partners
VC Fund
|
14 | United States, Israel, Canada | Series B, Series C, Series A | Software, Health Care, Information Technology | $5M–$68M |
|
New Enterprise Associates
VC Fund
|
14 | United States, India, United Kingdom | Series A, Series B, Series C | Software, Health Care, Biotechnology | $6M–$102M |
|
Founders Fund
VC Fund
|
14 | United States, United Kingdom, Germany | Series A, Seed, Series B | Software, Health Care, Information Technology | $1.7M–$100M |
|
Life Science Angels
VC Fund
|
14 | United States, Israel, The Netherlands | Seed, Series A | Biotechnology, Health Care, Medical | $1M–$10M |
|
Horizon Technology Finance
VC Fund
|
14 | United States, Canada, India | Debt Financing, Post-IPO Debt, Venture - Series Unknown | Health Care, Biotechnology, Medical Device | $5M–$45M |
|
Versant Ventures
VC Fund
|
14 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $5M–$108M |
|
Ben Franklin Technology Partners of Southeastern Pennsylvania
VC Fund
|
14 | United States | Seed, Debt Financing, Grant | Health Care, Software, Information Technology | $5k–$2M |
|
SBXi
VC Fund
|
14 | United States, India, Mexico | Pre-Seed, Seed, Venture - Series Unknown | Artificial Intelligence, Software, Information Technology | $100k–$7M |
|
Social Starts
VC Fund
|
13 | United States, Canada, Germany | Seed, Series A, Pre-Seed | Software, Health Care, Artificial Intelligence | $100k–$14M |
|
Catalyst Health Ventures
VC Fund
|
13 | United States | Series B, Series A, Series C | Health Care, Medical Device, Biotechnology | $1.3M–$85M |
|
Silicon Valley Bank
VC Fund
|
13 | United States, Canada, United Kingdom | Debt Financing, Series B, Series A | Software, Health Care, Biotechnology | $2M–$115M |
|
Cultivation Capital
VC Fund
|
12 | United States, Australia, Canada | Seed, Series A, Series B | Software, Health Care, SaaS | $500k–$38M |
|
St. Louis Arch Angels
VC Fund
|
12 | United States, Argentina | Seed, Series A | Biotechnology, Health Care, Medical Device | $100k–$8.5M |
|
Mayo Clinic
VC Fund
|
12 | United States, Canada, Israel | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $100k–$100M |
|
Boutique Venture Partners
VC Fund
|
12 | United States, Canada, France | Seed, Series A, Pre-Seed | Health Care, Medical, Biotechnology | $1.8M–$31M |
| Access all 5623 investors in United States Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Founded in 2007 by the Memphis Bioworks Foundation, Innova is a pre-seed, seed and early-stage investor focused on starting and funding high-growth companies in the Biosciences, Technology and AgBio fields across the state of Tennessee. Innova links capital with great ideas to create groundbreaking products and services.At Innova we invest instart-up companies, help them grow, and then assist them in linking with established corporations for licensing, buy-outs or further investments. We provide the synergy of experienced management, market expertise and venture capital to accelerate the development of new products and services into viable business units that can stand on their own and then take their place with a mature market leader, if desired.Whether an innovation is still on the drawing board or stalled in the market place the Innova staff has the expertise, skills, and experience to envision and create a functioning business unit that is prepared to thrive in the market place. Technical know-how, market-proven staffing, and "just-right" funding assure the greatest chance possible for success.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United States, Germany, Argentina
Investor stats
- Total investments: 278
- Round size: Seed $25k–$1.6M; Pre-Seed $25k–$1.3M; Convertible Note $250k–$1.4M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — raised $40M in 2023
Portfolio highlights
- HerdDogg — HerdDogg is a global herd health and data science platform. It is a two-part system that helps ranchers track health and proximity data from their herd. The company's device gathers the data captured by the ear tags and reports it directly to the rancher via an app or web database.
- Insignum AgTech — Insignum AgTech develops biotech plants that communicate with producers, alerting them to an illness in its early stages.
- Rescue Forensics — Customer service is our #1 priority. Get a premium domain for your website today. Financing available.
Access curated startup investment opportunities and diversified venture capital exposure designed for accredited investors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 2682
- Round size: Seed $880k–$9.9M; Series A $3.5M–$32M; Series B $8M–$75M
- Lead/follow: 4% lead, 96% follow
- Last fund: Likely actively investing — fresh fund, raised $90k in 2026
Portfolio highlights
- LOLIWARE — LOLIWARE is rewriting the story of destructive packaging. By harnessing the power of seaweed to replace plastic at scale, LOLIWARE is tapping into its potential to regenerate our ocean and decarbonize our planet.
- Talk Local — Need a service professional? Search the Nation's #1 Service Directory. It's Free and Fast, get connected over the phone instantly with Local Plumbers, Accountants, Computer Repair Pros, Dentists, Heating & Cooling HVAC, and other service professionals!
- HopSkipDrive — Arranging safe, dependable transportation or children ages 6+ with qualified caregivers
Investing Funds Designed for Women Backing Innovative Companies We Want in the World - For Returns and Impact
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Germany
Investor stats
- Total investments: 312
- Round size: Seed $1.2M–$5.3M; Series A $347k–$15M; Series B $5M–$51M
- Lead/follow: 6% lead, 94% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Kind Designs — Kind Designs is a trusted 3D Printed seawall contractor in Miami offering custom seawall construction, shoreline protection, erosion control solutions.
- AEENA Dx — A brilliant shift in disease detection is coming soon. Learn more A brilliant shift in disease detection is coming soon. Learn more
- Adjuvia Therapeutics — Adjuvia Therapeutics develops orally delivered, BBB-penetrant nanoparticle therapies that carry nature's most potent antioxidants into the brain, CNS, and organs to treat chronic and rare degenerative diseases.
TEDCO is an independent organization that strives to be Maryland’s lead source for entrepreneurial business assistance and seed funding for the development of startup companies in Maryland’s innovation economy.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Grant, Pre-Seed
- Geography: United States, Canada, Colombia
Investor stats
- Total investments: 340
- Round size: Seed $100k–$2.5M; Grant $54k–$1M; Pre-Seed $25k–$900k
- Lead/follow: 70% lead, 30% follow
Portfolio highlights
- Washington College — One of the oldest leading liberal arts colleges, Washington College offers uniquely traditional and personalized academic experiences.Situated in Chestertown along Maryland’s Chester River, Washington College exists in one of America’s most well-maintained historical communities.One particularly outstanding academic program at WashingtonCollege is its Starr Center for the Study of American Experience. This center brings scholars and students together to discuss and study traditional history in new ways. Starr Center Faculty also publish regularly in such places as The Washington Post, National Geographic, Smithsonian and The New York Times.Other academic areas of study include Anthropology, Art History, Black Studies, Clinical Counseling, Drama, Education, Engineering, Humanities and International Literature.Personalized in its approach, Washington college boasts a low student-faculty ratio, ensuring that students receive as much attention from faculty as possible.Students may complete their experience by living in on-campus residences and participating in Washington College’s academic, recreational or athletic organizations.Financial aid options at Washington College include standard grants, loans, work-study and scholarships for those who qualify.
- Rockville Science Center — Rockville Science Center provides opportunities for people to engage in science and engineering activities.
- Allegany College of Maryland — The main campus of the Allegany College of Maryland rests in Cumberland, off of Willow Brook Road. As the biggest of the school’s three campuses, Cumberland has all of the amenities you may never have expected from a small college. Each building is equipped with the latest modern facilities, making for an up-to-date learning experience. There arealso dining areas, a student lounge, and a state of the art physical education building with a gym and swimming pool.Within the list of extensive fields of study are the social, biological and political sciences, criminal justice and criminology, many fields in the humanities, accounting and business programs, automotive and other technical studies, culinary arts, hotel and restaurant management, forest technology, health fields including dental hygiene, physical education, nursing, and pharmacy technician studies, and more. Advice is not something you’ll be lacking at Allegany. The tutoring services can help you through any academic rough patches. Transfer advising can prepare you to go to a four-year college. Career advising counselors can help you pick a major, assess your interests and aptitudes, and help find you a career.Along with federal financial aid and veteran’s benefits, Allegany also offers a catalog full of scholarships from major related aid to local endowments to eligible students.
Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 1335
- Round size: Seed $1M–$8.2M; Series A $5M–$35M; Series B $16M–$100M
- Lead/follow: 1% lead, 99% follow
- Last fund: Likely actively investing — fresh fund, raised $140k in 2026
Portfolio highlights
- Epirus — Epirus is a high-growth technology company that develops cutting-edge directed energy systems and power management solutions to transform multiple industries.
- BQP — At BQP, we’re developing a quantum-accelerated digital twin platform for mission-critical applications. The platform, BQPhy, is a back-end engine that integrates seamlessly into existing engineering workflows and operates on today’s infrastructure without requiring quantum hardware. BQPhy helps teams solve large-scale, complex challenges inengineering optimization, data-driven modeling (ML), and physics-based (CFD) simulations. We are bridging the gap between current high-performance computers and future quantum systems with probabilistic algorithms from quantum information science, unlocking simulation capabilities that were previously impractical or impossible. BQPhy reduces time, accuracy, and throughput inefficiencies, thereby accelerating development cycles, unlocking previously unexplored design spaces, lowering costs, and enhancing product outcomes.
- Sharper Sense — Neuromodulation for Clear Senses
For over two decades, Sand Hill Angels has worked openly and collaboratively with venture capital funds, other angel organizations, and the Bay Area ecosystem that fosters the growth of technology startups.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Convertible Note, Series A
- Geography: United States, Canada, India
Investor stats
- Total investments: 567
- Round size: Seed $1M–$6.2M; Series A $1.9M–$20M; Convertible Note $300k–$25M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- PlusPlus — PlusPlus provides a learning and development SaaS platform for technical professionals. It automates the management of onboarding, workshops, and tech-talks at scale. With PlusPlus, companies attract and develop employees.
- Clean Power Finance — Clean Power Finance (CPF) is building an online business-to-business marketplace to drive the mass-market adoption of solar. The company connects providers of capital who are committed to investing in residential solar with qualified solar marketers, installers and distributors who need residential solar finance products to differentiate and growtheir businesses. CPF raises 100 percent third-party‐owned project finance funds from institutional investors such as Morgan Stanley and Google, working with the investors to structure and launch the funds with managed risk and return profiles. CPF then markets the funds as solar leases and power purchase agreements (PPAs) to qualified solar professionals, including Paramount Solar and Real Goods Solar (Nasdaq: RSOL), through its licensed online solar sales platform, CPF Tools. CPF Tools is software-as-a-service that simplifies complex sales, quoting, proposal and finance processes and minimizes the “soft costs” of selling solar.CPF’s fund investors earn favorable returns on stable investments on the resulting portfolios of residential distributed generation projects. The company’s solar professional partners gain access to solar leases and power purchase agreements (PPAs) that they can brand and sell to homeowners who want the benefits of solar without the cost and hassle of owning and maintaining a system.CPF manages approximately half a billion dollars of capacity on behalf of fund investors, and supports more than 100 solar professional customers who currently use the CPF Market to sell residential solar finance products to homeowners in CA, CO, HI, MA and NJ. Thousands of solar professionals in all 50 states have extensively used CPF Tools to quote and design solar systems.
- Magnetic Insight — Magnetic Insight (MI) introduced magnetic particle imaging into the preclinical diagnostic research market enabling quantitative cell tracking, imaging of vascular function, detecting metastatic tumors, visualizing inflammation, CAR-T cell therapies and initial research into regenerative medicine.
Systematic Pre-Seed Startup Capital
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 1881
- Round size: Seed $50k–$2M; Pre-Seed $50k–$450k; Convertible Note $50k–$400k
- Lead/follow: 3% lead, 97% follow
- Last fund: Likely actively investing — fresh fund, raised $55M in 2025
Portfolio highlights
- tbh — tbh is a developer of a mobile application designed to provide anonymous feedback to friends. The company's mobile application facilitates asking or answering questions, open text fields and invite abuse when combined with anonymity, enabling users to say things without repercussions and feel better about themselves from the positive feedbackon social networks.
- Vidrovr — Vidrovr develops multimodal computer vision and machine learning systems to index, tag, and understand video. It processes videos with specific domain constraints, such as in sports, government, and media verticals. Its technology enables its users to search an indexed video corpus and retrieve content inside videos and link it to other media likephotos and text.The company Integrates social media to enable direct interactions between multimedia content. Vidrovr was founded in 2016 and is headquartered in New York.
- Experio AI — Turn contracts, proposals, and expertise into instant searchable intelligence. Win more, ramp faster, never lose knowledge. Enterprise AI for services.
Launch NY is a U.S. Treasury-designated Community Financial Institution (CDFI) and a 501(c)(3) nonprofit venture development organization, providing pro bono mentoring and capital access to high-growth potential startups across Upstate NY. The mission is to identify, support and invest in high-growth, high-impact companies, and catalyze theentrepreneurial culture in the 27 counties comprising the western half of Upstate New York.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Convertible Note, Seed, Pre-Seed
- Geography: United States, Canada, Denmark
Investor stats
- Total investments: 248
- Round size: Seed $50k–$2.2M; Pre-Seed $81k–$1.1M; Convertible Note $18k–$1M
- Lead/follow: 61% lead, 39% follow
- Last fund: Likely still investing — raised $16M in 2023
Portfolio highlights
- Ognomy Sleep — Are you looking for a sleep apnea app? Ognomy brings the high-quality care you can expect from an online sleep doctor. Our mission is to improve global health by democratizing access to care for those who suffer from sleep apnea - over 1 billion people worldwide.
- CryoBio — CryoBio offers a food-safe spray solution to protect crops from extreme frost, reducing losses and replacing manual labor with effective, biodegradable frost protection technology.
- Bridge Green Upcycle — Bridge Green Upcycle is a clean energy company that specializes in lithium-ion battery upcycling technology solutions.
Khosla Ventures is a venture capital firm that invests in early- to late-stage companies across sectors like AI, healthcare, sustainability, and consumer technology. It manages multiple funds, focusing on startups with innovative technologies or business models. The firm primarily targets sectors like AI, climate tech, digital health, and medtech,offering strategic support to help build long-lasting companies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Series B, Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1407
- Round size: Seed $2M–$23M; Series A $5.5M–$47M; Series B $11M–$100M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely actively investing — fresh fund, raised $31M in 2026
Portfolio highlights
- Vectra AI — Vectra AI, the cybersecurity AI company that protects modern networks from modern attacks.
- LanzaTech — LanzaTech is turning our global carbon crisis into a feedstock opportunity with the potential to displace 30% of crude oil use today and reduce global CO2 emissions by 10%. By recycling carbon from industrial off-gases; syngas generated from any biomass resource (e.g. municipal solid waste (MSW), organic industrial waste, agricultural waste); andreformed biogas, LanzaTech can reduce emissions and make new products for a circular carbon economy.LanzaTech’s carbon recycling technology is like retrofitting a brewery onto an emission source like a steel mill or a landfill site, but instead of using sugars and yeast to make beer, pollution is converted by bacteria to fuels and chemicals! Imagine a day when your plane is powered by recycled GHG emissions, when your yoga pants started life as pollution from a steel mill. This future is possible using LanzaTech technology.
- littleBits Electronics — LittleBits is an open source library of over 60 electronic modules that snap together with magnets allows users to view, download, and share designs and make their own Bits through the use of prototypes. Deluxe kit, Smart home kit, Arduino coding kit, Synth kit, hardware development kit, and workshop set are some of the electronics learning modulesprovided by littleBits.LittleBits was launched by Ayah Bdeir in 2011 and is operated from New York, United States.
Keiretsu Capital LLC is an affiliate of the World's Leading Angel Network, Keiretsu Forum, and manages funds which enable limited partners to co-invest in the proprietary deal flow of the angel investors.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Convertible Note, Seed
- Geography: United States, Canada, India
Investor stats
- Total investments: 271
- Round size: Seed $465k–$2.5M; Series A $1M–$12M; Convertible Note $50k–$3M
- Lead/follow: 1% lead, 99% follow
- Last fund: Likely still investing — raised $3.7M in 2022
Portfolio highlights
- MiClient — Miclient are deal closure platform which was founded by experienced sales leaders who recognized the need for a new generation of complicated quote configuration, contract signing, renewal & payment collection at one place for SMEs, Lead Management System, B2B SaaS, CRM software, CPQ (Configure- Price- Quote)
- Healionics — Healionics aims to provide safer, more reliable means of bloodstream access for dialysis in patients with kidney failure.
- NuvOx Therapeutics — NuvOx Pharma is a clinical stage biotech company developing an innovative platform of oxygen therapeutics to treat life-threatening diseases where hypoxia plays a role.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 292
- Round size: Seed $150k–$5.3M; Series A $2.1M–$25M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- eBrevia — Analyze contracts at scale, extract key data, and identify risk with eBrevia. Draft and redline agreements in Microsoft Word with DraftPro.
- Mobile Sense — The traditional diagnostic market is being transformed by advances in high performance wearables. This seismic shift led by consumer products which are uncovering new patients who previously went undetected, but still require a detailed diagnosis. Mobile Sense™ is building foundational technology that enables this transformation throughoff-the-chest wearables for long term management of cardiac arrhythmias. Developed over 7 years with $4.2M in grant funding and $1.3M in seed funding, Mobile Sense™ has a platform for differentiated wearables. Our embedded algorithms coupled with non-adhesive, wireless & waterproof sensors provides high fidelity continuous ECG and PPG recordings. The automatic monitoring provides 24/7, 365 days/yr continuous detection and classification of dangerous heart arrhythmias.
- NovaTract Surgical — NovaTract Surgical is a development stage company, intends to develop medical devices to address the rapidly growing field of Single Incision Laparoscopic Surgery (SILS) and Natural Orifice Transluminal Endoscopic Surgery (NOTES). The company was incorporated in 2010 and is based in Guilford, Connecticut.
CincyTech helps to identify and transform innovation into venture-worthy, transformational human health and technology companies, primarily in southwest Ohio. Our team provides advice and capital to entrepreneurs, helps research institutions commercialize technology through startups, and catalyzes investment from individuals and institutions intoregional companies. One of the most active seed funds in the Midwest, CincyTech is supported by Ohio Third Frontier, more than two dozen foundations, corporations, municipalities and individuals as well as founding partners, Cincinnati Children’s Hospital Medical Center, the University of Cincinnati, and the Cincinnati USA Regional Chamber.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States
Investor stats
- Total investments: 130
- Round size: Seed $250k–$3.9M; Series A $300k–$20M; Series B $2.5M–$11M
- Lead/follow: 53% lead, 47% follow
- Last fund: Likely still investing — raised $2.8M in 2022
Portfolio highlights
- Invirsa — Invirsa is developing a unique, broad platform based on a naturally occurring small molecule (INV-102) that has demonstrated enhanced immune response to infection. INV-102 not only reduces viral infection, and potentially bacterial replication, it also reduces inflammation, while enhancing the bodies wound healing response. Invirsa'stechnology is first being developed in the ophthalmology and pulmonary space.Invirsa’s technology has the potential to be a first line therapy for common infectious diseases, whether it's the 100 million viral pulmonary infections or the 5 million infectious conjunctivitis cases that occur every year in the US alone.
- TeamCentral — TeamCentral is a company focused on optimizing productivity through improvements in how data is managed and governed across business systems.
- Ravee Optics — Ravee Optics is a startup company developing ultracompact optical intersatellite links and hardware technology for high data rate communications and data transfer for small satellites and cubesats
TCA Venture Group is the largest angel investor group in the United States, possessing more than 300 members in five networks in Los Angeles, Orange County, San Diego, Central Coast, and the Inland Empire. Its members provide funding and guidance to more early-stage, high-growth companies in Southern California than any other investment group.Members invest in companies in a wide range of industries, including the life sciences, biotech, IT, services, retail, Internet, financial, software, media, consumer products, and tech startups. TCA as a whole gives companies more than just capital; they also provide counsel, mentoring, and access to an extensive network of potential investors, customers, strategic partners, and management talent. Tech Coast Angels has been ranked by CB Insights to be among the Top 20 Angel Groups in the US; TCA was also ranked as #1 for Network Centrality, meaning we have more connections than anyone! If you are in the game-changing business, we are here to help.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Convertible Note, Venture - Series Unknown
- Geography: United States, Canada
Investor stats
- Total investments: 350
- Round size: Seed $600k–$4M; Convertible Note $50k–$7M; Venture - Series Unknown $400k–$8.5M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- EdgeX — Edokonta builds software that allows hospitals to track mobile equipment, such as IV pumps and ultrasounds. The company was founded in 2018 and based in San Diego, California.
- Nested Knowledge — Nested Knowledge is designing an interface that allows you to examine the data from a comprehensive literature review on research questions of interest. The interactive, nested features facilitate therapeutic comparisons, assist with research organization, and allow physicians to compare nuances across patient characteristics and outcomes.
- Major Medical Devices — Major Medical Devices develops next-generation vascular devices for endovascular repair and related surgical procedures.
Private angel investors and corporate venture ecosystem investing in healthtech, digital health and other healthcare technologies startups
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A, Convertible Note
- Geography: United States, Canada
Investor stats
- Total investments: 99
- Round size: Seed $1M–$3.4M; Series A $1.7M–$16M; Convertible Note $1.3M–$2.5M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- S2 Genomics — S2 Genomics is developing spatial sequencing technology solutions for processing solid tissues for single-cell applications. It enables automated processing of raw tissues into single cells or nuclei for genomics and cell biology studies. The company's vision is to provide products that process raw tissues into samples ready for genomicanalyses.S2 Genomics was founded in 2016 and is headquartered in Livermore, CA.
- Journey Live — Journey is shifting the way modern companies prioritize mental health. Our proactive, inclusive tools engage every employee, every day.
- GT Metabolic Solutions — GT Metabolic Solutions has developed minimally-invasive incisionless bypass technology for bariatric, metabolic and digestive surgery.
New York Angels is one of the oldest, most prominent angel investment groups in the country. New York Angels has offered early-stage entrepreneurs funding, mentoring, connections and more for over 20 years. Angel investors join New York Angels for their extensive, experienced network, increased de
Show more...Investment focus
- Industry: Software, Health Care, Mobile
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 369
- Round size: Seed $365k–$5M; Series A $1.1M–$10M; Series B $2M–$15M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $2.4M in 2022
Portfolio highlights
- Solidec — Solidec is the pathway to emission-free compounds, beginning with hydrogen peroxide.
- Epicured — Epicured delivers gourmet low-FODMAP, gluten-free meals by chefs for digestive health. Tasty cuisine right to your door.
- YourCoach Health — Health and Wellness coach practice management solution enabling coaches to holistically lead their clients, connecting mind, body and soul through behavior modification and accountability tools towards outcomes
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Good Growth Capital is an early-stage venture capital firm known for its expertise in finding, assessing and cultivating complex science and technology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Convertible Note
- Geography: United States, France, Israel
Investor stats
- Total investments: 130
- Round size: Seed $505k–$8.2M; Series A $4.2M–$24M; Convertible Note $25k–$300k
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $43M in 2023
Portfolio highlights
- Ateios — Ateios is enabling a new generation of thin and flexible electronics with our ultra-thin, conformable, and customizable batteries. The company's current focus is zinc-oxide batteries, that achieve 2-5x higher energy density compared to coin cells. Ateios’ novel manufacturing process allows customizable batteries that can be shaped around theneeds of the product.The company was founded in 2018.
- Obsidio — Obsidio™ Conformable Embolic with aqueous gel technology is a 510(k) cleared device, the first of its kind to have a specific on-label indication for peripheral use in the U.S.
- Avisi Technologies — Avisi Technologies is developing a nanotechnology-enabled defense against blindness from glaucoma.
Eniac Ventures is a venture capital firm that focuses its seed-stage investments in technology, software, robotics, and SaaS startups. The firm partners with bold founders to help them achieve product-market fit and grow their companies from inception to success. With each fund, the approach of Eniac Ventures has evolved and expanded to addressthe growing needs of portfolio companies. Founders are encouraged to focus on their product, which led to the creation of the Eniac Platform. Term sheets represent just the initial step; companies partnering with Eniac benefit from a range of complimentary support services.These include access to a talent recruiter dedicated to finding top employees, particularly in engineering, as well as a public relations and marketing specialist to help products reach key audiences from launch through growth. Additionally, operational resources are provided to help organize staff and implement best practices.Business development and networking opportunities are available with thousands of leading companies, investors, and brands. Furthermore, connections to other founders within Eniac’s portfolio facilitate the exploration of synergies and opportunities. Fundraising support encompasses guidance on pitch decks, strategies for follow-on investors, and syndicate building.
Show more...Investment focus
- Industry: Software, Information Technology, Mobile
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 528
- Round size: Seed $1.7M–$6.2M; Series A $8M–$20M; Series B $8M–$40M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $12M in 2024
Portfolio highlights
- Origin Lab — Origin Lab licenses premium content from game studios and 3D universes - delivering structured, multimodal data for AI training.
- Attention — Attention is a powerful conversational intelligence software that helps you coach and ramp up your sales reps into top performers.
- Nebex — NEBEX is a successful middle market investment intermediary. NEBEX, has completed over 100 transactions throughout the United States. New England Business Exchange concentrates on representing sellers whose business appeals to large corporate buyers or private equity groups.
Early Stage Venture Investments
Show more...Investment focus
- Industry: Health Care, Medical Device, Software
- Stage:Seed, Convertible Note, Series A
- Geography: United States, Canada, Hungary
Investor stats
- Total investments: 102
- Round size: Seed $105k–$3M; Series A $3M–$10M; Convertible Note $2.5M–$2.6M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $175k in 2021
Portfolio highlights
- Flourish Care — FlourishFund is a digital platform that empowers and supports new and expecting families. The platform consists of two parts: a marketplace with evidence-based goods and vetted maternal wellness services and a funding mechanism for friends and families to contribute to a positive birth and parenting journey.
- Drusolv Therapeutics — Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention in age-related macular degeneration. Their product ocustatin is aimed at patients who are still in the intermediate stage of the disease and currently have very limited options to prevent progression to late-stage vision loss. Ocustatinwas developed at Harvard University and has been validated in a very successful proof-of-concept clinical trial that showed a 75% reduction in progression to late-stage blindness. John Edwards, the founder and CEO of Drusolv, is a serial entrepreneur with extensive experience in AMD.
- Vartega — Vartega is a technology development company specializing in the carbon-fiber-reinforced plastic recycling process. Vartega develops alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass-market applications.Vartega's patented carbon fiber recycling process scales rapidly to fill a gap in thecomposites supply chain. The company’s carbon fiber is available in semi-continuous, chopped, and milled forms. It is ideally suited for use in thermoplastics, non-wovens, and molding compounds.
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Series B
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 83
- Round size: Seed $1M–$18M; Series A $1M–$20M; Series B $7M–$45M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Adient Medical — Medical Devices that Automatically Vanish - Adient Medical is leading the development of an absorbable vascular filter for the prevention of pulmonary embolism.
- HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
- Viridian Therapeutics (Formerly MiRagen Therapeutics) — Committed to developing potential best-in-class medicines for people affected by Thyroid Eye Disease and other autoimmune and rare diseases.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Keiretsu Forum is a global angel investor network with more than 2,500 accredited investor members throughout 47 chapters on 3 continents.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Series A
- Geography: United States, India, Turkey
Investor stats
- Total investments: 374
- Round size: Seed $102k–$3M; Series A $600k–$8.6M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $10M in 2015
Portfolio highlights
- Bliss — Skip long waitlists and expensive therapy. Book licensed online therapists in multiple languages with culturally informed care.
- BatteryPool — BatteryPool offers battery charging solutions for EV fleets and commercial vehicles.
- Apriority Financial — Apriority Financial is a debt optimization platform that manages and optimizes employee personal debt.
MB Venture Partners in Memphis, TN provides venture capital for life sciences: medical device, biotechnology companies, products for musculoskeletal diseases
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Series B, Series C
- Geography: United States, Israel
Investor stats
- Total investments: 91
- Round size: Seed $50k–$800k; Series B $1.3M–$18M; Series C $5M–$28M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $22M in 2011
Portfolio highlights
- Cast21 — The future of orthopedic technology has arrived. Cast21 braces are designed for your active lifestyle.
- SweetBio — SweetBio is a Memphis, Tennessee based medical device company specializing in bioengineering honey-incorporated materials for wound care.
- Lineus Medical — Lineus Medical is a medical device company focused on reducing IV complications for patients and providers all over the world.
Wavemaker Three-Sixty Health is the leading U.S. early-stage (Seed and following on at the Series A) venture capital fund focused 100% on healthcare. Launched in 2018, Wavemaker 360 invested into the most promising healthcare startups in North America, with LPs from every sector of the US healthcare system. We are SEEDING HEALTHCARE'STOMORROW. We invest in healthcare disruptors and entrepreneurs that see how the industry is transforming itself and want to make a big difference.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 92
- Round size: Seed $700k–$6M; Series A $100k–$20M; Series B $5M–$30M
- Lead/follow: 11% lead, 89% follow
- Last fund: Likely still investing — raised $2.2M in 2023
Portfolio highlights
- Tombot — We create robotic animals that transform the daily lives of individuals, families, and communities facing health adversities. Reserve your Tombot Puppy today for FREE
- Materna Medical — Materna Medical empowers women to protect and restore their pelvic health.
- ChemT Biotechnology — The goal of ChemT Biotechnology is to increase patient access to the most cutting-edge biologics, beginning with the urgent issues in manufacturing and research and development.
North Coast Ventures (formerly North Coast Angel Fund) is comprised of four contributed capital funds with a focus on early-stage technology investments. Our membership consists of a number of Ohio's leading investors, entrepreneurs, and business leaders who are dedicated to accelerating early-stage ventures.North Coast Ventures members playan active role by generating deal flow, serving on due diligence teams, working with portfolio companies, or serving on the Investment Screening and Executive Committees. Through this involvement, our goal is to provide a supportive environment for our portfolio companies and ultimately enhance the performance of our Fund.Northeast Ohio has a long tradition of active and successful angel investing, but until recently, the success of this crucial form of funding has hinged on the efforts of a relatively small number of individual investors. As the region’s first professionally managed angel fund, North Coast Angel Fund works to improve the early-stage funding environment for both entrepreneurs and investors.
Show more...Investment focus
- Industry: Health Care, Software, Medical Device
- Stage:Series A, Seed
- Geography: United States
Investor stats
- Total investments: 102
- Round size: Seed $500k–$5.5M; Series A $1.2M–$14M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- FinOpsly — Maximize your cloud ROI with FinOpsly. Our AI-driven platform empowers organizations with smart cost management, fostering collaboration across teams for over 32% in savings. Simplify your cloud strategy with FinOpsly.
- InnerActiv — InnerActiv is the leading NextGen eDLP solution, setting new standards in DLP, fraud and insider threat detection.
- Healia Health — Healia is a company that provides revolutionizing health insurance for dual-income households, saving employers 85% each registered family.
Wisconsin Investment Partners is an Angel Investment Group in Madison, Wisconsin founded in 2000 with 20 members. Membership has grown to 50+ members in recent years, bringing significant knowledge and experience.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Venture - Series Unknown
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 120
- Round size: Seed $400k–$3M; Venture - Series Unknown $380k–$12M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- DropCap — International Rights Platform for Books | DropCap
- Cylerity — Transform healthcare receivables into real-time capital. Cylerity unlocks cash flow, clarity, and control from claims data. See how it works.
- Midwest Games — Midwest Games is a video game publisher focused on creating opportunities for the abundant talent across the Midwest and other underrepresented regions.
Providing Flexible and Creative Financial Solutions to Middle Market Companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Debt Financing, Post-IPO Debt, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 129
- Round size: Series B $39M–$76M; Post-IPO Debt $15M–$150M; Debt Financing $7.5M–$96M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- Inhibrx — Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The Inhibrx pipeline is focused on oncology,orphan diseases, and infectious diseases. Inhibrx has collaborations with Celgene and Bluebird Bio and has received awards from several granting agencies, including NIH, NIAID, and CARB-X.
- Vortexa — State of the art energy analytics that paints a global picture of cargo flows. Identify energy market opportunities before the competition with Vortexa.
- Serena & Lily — Design-driven luxury furniture, bedding, home accessories & interior design. Explore Serena & Lily's proprietary products and personalized service to create a home on your own.
For over 20 years we have been a successful healthcare venture capital firm rooted in the Midwest. Check out our portfolio companies.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 117
- Round size: Series A $4.4M–$27M; Series B $5M–$55M; Series C $10M–$80M
- Lead/follow: 46% lead, 54% follow
- Last fund: May invest from a new fund soon — raised $250M in 2019
Portfolio highlights
- Endogenex — DyaMX is an early stage medical device company focused on the treatment of Type 2 Diabetes
- Boomerang Medical — Boomerang Medical is a bioelectronic medicine company targeting autoimmune diseases.
- Pharaoh Neuro — Pharaoh Neuro develops a neurapheresis cerebrospinal fluid management system for neurological patients.
Golden Seeds is a seed-stage investment firm with a focus on women leaders. Their investment thesis rests on the extensive research that concludes that gender-diverse teams produce a better return on equity. By seeking companies where women hold leadership positions and own substantial equity, they are funding companies that are likely to havediverse perspectives that will contribute to success.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: United States, Canada
Investor stats
- Total investments: 157
- Round size: Seed $740k–$5.6M; Series A $1.2M–$10M; Series B $1.8M–$20M
- Lead/follow: 20% lead, 80% follow
- Last fund: Likely actively investing — fresh fund, raised $1.2M in 2025
Portfolio highlights
- RenovoRx — RenovoRx is a developing innovative solutions for targeted delivery of fluids, including diagnostic and therapeutic agents, to selected sites in the peripheral vascular system. RenovoRx received FDA clearance for the RenovoCath™ RC120 and is currently introducing this innovative technology to the clinical market.RenovoRx has a motivatedManagement Team with broad experience and an exciting vision for the future of targeted delivery. The company also has a broad Advisory Board of interventional radiologists, surgical oncologists and gastroenterologists that guide the company's clinical development strategies. RenovoRx is backed by a strong Board of Directors committed to long-term, continuous support of the company, whose members provide critical expertise in the medical and biotechnology industry and the visionary thinking to succeed.
- Little Pim — Little Pim Corporation is an NYC-based company that produces and distributes the premier language learning program for children aged 6 months to 6 years. Little Pim is distributed through several channels: directly to consumers through the company website, through a variety of online retailers and brick-and-mortar stores that carry Little Pim, andas a turnkey program for use in daycares.
- Style for Hire — Style for Hire is a national network of trained and certified personal stylists who bring affordable in-home wardrobe advice and shopping assistance to customers. Celebrity stylist Stacy London, from TLC's What Not to Wear, is co-founder, spokesperson, and Stylist-in-Chief.
Boston Harbor Angels is a group of proven business leaders interested in investing a portion of their assets in high growth, early stage companies. The group was formed in February 2004 and since then has made a number of investments in companies in medical devices, IT, consumer products, business products, specialty materials, Internet, aviation,etc. They believe they contribute more than money to the companies they fund and welcome the opportunity to work with entrepreneurs open to take advice, yet having the smarts and determination to make the company successful.Their focus is on early stage companies usually looking to raise $250K to $1.5M, where they can fund a portion of the round and syndicate the deal with other angel groups or early stage venture funds. The stage of the company should be close to commercialization, while the company should have a clear and defensible competitive advantage. They are looking for capital efficient businesses, which can reach profitability with less than $5M of equity investment and provide at least 10X return on the investment within 5 years.They do not invest as a fund - each of their members makes his or her individual investment decision but they collaborate in Due Diligence. They have a deep expertise in the life sciences field where they usually take the position of a lead investor, but are open to any opportunities that can make a strong business case. In some cases they prefer to be the follow on investor if they cannot identify a person with strong expertise within their group.The group’s strategy is directed by an executive committee which consists of 8 people elected by the group: Wayne Griffith (chairman), Bill McPhee, Henry Kay, Jay Schwartz (membership director), Steve Andress, Peter Miller, Don Freeman and Mic Williams (president and founder). The group’s day-to-day operations are managed by Boris Batchvarov (managing director).They receive 20-30 business summaries each month, out of which they select 8 companies to make a personal presentation to their screening committee. The screening committee consists of volunteers from the group. The presentations are 10 min long followed by 10 min Q&A. 4 of the companies are invited to present to the whole group, with the idea to get the people interested and decide to perform a Due Diligence with the companies before making an investment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Angel, Seed, Series A
- Geography: United States, Canada, India
Investor stats
- Total investments: 109
- Round size: Seed $100k–$2.9M; Angel $500k–$1.6M; Series A $662k–$6M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Gelmedix — Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment. The company's platform offers a single non-invasive gel patch that can be used as a drug-eluting sealant with tissue adhesion, tunable drug elution, and biocompatibility properties, thereby enabling healthcare providers to reducethe usage of drops which cause inconvenience to patients.
- Zylö Therapeutics — Patented technology that enables, for topicals, sustained release, increased druggability, a Patchless Patch concept, and enhanced targeting of pores and follicles
- Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Maine Angels they make investments with entrepreneurs with an emphasis on businesses.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Series A
- Geography: United States
Investor stats
- Total investments: 129
- Round size: Seed $25k–$1.2M; Series A $662k–$5.9M
- Lead/follow: 1% lead, 99% follow
- Last fund: Likely still investing — raised $1.8M in 2022
Portfolio highlights
- Waku — Deliciously replenishing herbal tea with prebiotic powers and 0g of added sugar. Experience Sunrise on the Inside.
- HighByte — Architect your digital transformation and AI use cases with proven Industrial DataOps software from HighByte. Let's make your industrial data useful.
- Pumpspotting — connect over breastfeeding, milk, motherhood, and the best places to nurse and pump. nurse, pump, nourish, connect.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Rev1 Ventures is a venture studio in Columbus, Ohio providing tech startups with services, space, mentoring, and connections. Learn more!
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: United States, Germany
Investor stats
- Total investments: 223
- Round size: Seed $200k–$3.2M; Series A $1M–$18M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $10M in 2021
Portfolio highlights
- FinOpsly — Maximize your cloud ROI with FinOpsly. Our AI-driven platform empowers organizations with smart cost management, fostering collaboration across teams for over 32% in savings. Simplify your cloud strategy with FinOpsly.
- InnerActiv — InnerActiv is the leading NextGen eDLP solution, setting new standards in DLP, fraud and insider threat detection.
- Niobium Microsystems — The encrypted cloud has arrived.
Everywhere Ventures is a global pre-seed venture capital fund for founders, by founders. Click to read Everywhere VC, by Everywhere Ventures, a Substack publication with tens of thousands of subscribers.
Show more...Investment focus
- Industry: Software, Health Care, FinTech
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, Australia, India
Investor stats
- Total investments: 1303
- Round size: Seed $1M–$6.5M; Pre-Seed $250k–$2.5M; Series A $6M–$20M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely actively investing — fresh fund, raised $4.4M in 2026
Portfolio highlights
- Donna — Meet Donna, the AI assistant built for field sales teams. Save time, cut admin, and close more deals with less effort.
- Keebler Health — AI-Enabled Coding for Medical Billing Teams
- Neurometric AI — Making Intelligence Free | https://t.co/ZxWxeMBJt2 | https://t.co/W8nlLqYwQi
Founded in 2008, Par Equity is a venture capital firm that backs the most innovative, high growth technology companies in the North of the UK. Based in Edinburgh, Par invests across Northern England, Northern Ireland and Scotland.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Venture - Series Unknown, Seed
- Geography: United Kingdom, United States, Brazil
Investor stats
- Total investments: 253
- Round size: Seed $416k–$4.3M; Venture - Series Unknown $168k–$4.2M
- Lead/follow: 55% lead, 45% follow
- Last fund: Likely still investing — raised $122M in 2023
Portfolio highlights
- Fuuse — Fuuse is an electric vehicle charge point management system that enables your chargers to deliver more for you and your drivers.
- PathXL — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
- Skylark Lasers — UniKLasers specialises in single frequency, continuous wave DPSS lasers at mid- to high power. Suitable for Raman, Holography, Interferometry, Microscopy, Metrology, Quantum Technologies, and more
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more...Investment focus
- Industry: Health Care, Wellness, Medical
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 315
- Round size: Seed $100k–$4M; Pre-Seed $20k–$854k
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — raised $31M in 2018
Portfolio highlights
- AvoMD — AvoMD is reimagining clinical decision support with interactive point-of-care software, available standalone and via EHR integrations, and seamless content building tools.
- Hidoc Consult — Hidoc Consult: Boost your well-being with free consultations, 24/7 access to quality healthcare, complete privacy, user-friendly, and a trusted network of HCPs
- NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Discover. Innovate. Connect. Discover. Innovate. Connect. We support the Michigan State University research and innovation ecosystem with funding, programs, and spaces that turn ideas into real-world impact. Explore Our Impact Contact Us Explore Our Impact Contact Us Start Here: From research breakthroughs to high-growth startups and industry collaboration,
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, The Netherlands, Canada
Investor stats
- Total investments: 203
- Round size: Seed $20k–$5M; Pre-Seed $20k–$2M; Series A $2.1M–$50M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely still investing — raised $5M in 2022
Portfolio highlights
- Scorbit — Scorbit develops a platform for pinball players and pinball machine owners and operators.
- Motion Grazer AI — Motion Grazer AI develops a monitoring system to track livestock using a computer and a real-sense camera. The company's hardware platform, SIM, provides soil monitoring and health assessment to provide individual sensing, monitoring, and analyses to enable precision livestock farming (PLF) breeding for sows.The company was founded in 2020and is headquartered in East Lansing, Michigan.
- SAINTE — Sainte delivers proactive, trauma-informed support through a human-led, AI-powered platform. We help individuals build resilience while improving workforce retention for employers and reducing costs for healthcare systems. Make your comeback with Sainte.
U.S. Venture Partners (USVP) is a venture capital partnership, helping entrepreneurs transform their ideas and efforts into world-changing companies. The firm focuses on early-stage ventures in information technology and health care, where innovation is unbridled and has led to the creation of economic wealth and millions of jobs over the pastthirty-plus years of the firm's existence. Areas of particular interest to our investment professionals include enterprise software, IT security, consumer internet, mobile, and e-commerce, healthcare, and IT-enabled healthcare services. The USVP team consists of former entrepreneurs, technologists, corporate executives, financial professionals, and industry domain experts.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series B, Series C, Series A
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 454
- Round size: Series A $5M–$40M; Series B $7M–$50M; Series C $7.8M–$68M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $400M in 2022
Portfolio highlights
- Dotomi — We create enriched customer experiences that drive performance at the individual and business level, enabling marketing built on proof, not promises.
- Cagent Vascular — Cagent Vascular pioneers Serration Remodeling Therapy (SRT) creating controlled lines of weakness to release the internal elastic lamina, reducing recoil and increasing luminal gain in PAD angioplasty.
- Maneva — Maneva Copilot AI is able to interpret, summarize, and combine the diverse landscape of data that exists throughout your production facility, and deliver the appropriate content to the question provided at all levels of roles, whether it is operational supervisors, quality managers, and management, process engineers, or maintenance leads
Foundational partners to ambitious founders at every stage of company-building.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1926
- Round size: Series A $6M–$57M; Series B $10M–$90M; Series C $15M–$102M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $468M in 2024
Portfolio highlights
- Tabula — Tabula, Inc., a fabless semiconductor company, develops programmable logic devices for programmable logic, memory, and signal processing applications. It offers 3-D programmable logic devices that support a portfolio of soft IP cores, including DDR2 and DDR3 memory controllers, PCI Express, gigabit and 10 gigabit Ethernet, soft CPUs, sRIO, CPRI,and OBSAI; and Spacetime, a programmable logic architecture that reconfigures logic, memory, and interconnect at multi-GHz rates. Tabula, Inc. was formerly known as Everychip, Inc. The company was founded in 2003 and is based in Santa Clara, California.
- Moximed — Moximed Inc. is dedicated to improving the standard of care for patients with osteoarthritis, and is investigating therapies to treat a number of affected joints. The lead product, the KineSpring® Knee Implant System, is designed for patients with knee osteoarthritis.
- Apprenda — Apprenda is a software layer that transforms any infrastructure into a policy-driven, hybrid cloud application platform.
Founders Fund is a San Francisco based venture capital firm investing in companies building revolutionary technologies.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 1021
- Round size: Seed $1.7M–$14M; Series A $5.6M–$50M; Series B $15M–$100M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely actively investing — fresh fund, raised $6B in 2026
Portfolio highlights
- SwishX — Indias First Employee Savings Platform
- Numeric — Hundreds of teams streamline reconciliations, organize their close, and leverage AI for flux analysis and reporting with Numeric.
- Prime Intellect — Prime Intellect democratizes AI development at scale. Our platform makes it easy to find global compute resources and train state-of-the-art models through distributed training across clusters. Collectively own the resulting open AI innovations, from language models to scientific breakthroughs.
Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on healthcare investing, including medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United States, Israel, The Netherlands
Investor stats
- Total investments: 94
- Round size: Seed $1M–$4M; Series A $1.3M–$10M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- ATDev — ATDev builds robotic mobility and assistive technology for older adults and people with disabilities
- Journey Live — Journey is shifting the way modern companies prioritize mental health. Our proactive, inclusive tools engage every employee, every day.
- Trio Pharmaceuticals — Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors. These drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. The company was founded in 2018 and is headquartered in San Diego, California.
Horizon is a venture lending platform that offers structured debt products to life science and technology companies. Its team of investment and operations professionals has been providing debt capital to some of the most exciting companies for decades. The members of the Horizon team have, collectively, originated and invested more than $5 billionin venture loans to thousands of companies.The company was founded in 2003 and is headquartered in Farmington, Connecticut.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Debt Financing, Post-IPO Debt, Venture - Series Unknown
- Geography: United States, Canada, India
Investor stats
- Total investments: 111
- Round size: Post-IPO Debt $10M–$40M; Debt Financing $5M–$30M; Venture - Series Unknown $6.5M–$45M
- Lead/follow: 71% lead, 29% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Ossio — OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.
- Stellar Cyber — Stellar Cyber: Automation-Driven, Open & Unified SecOps Platform with AI SIEM, NDR, Open XDR, and Multi-Layer AI.
- Hyperfine — Hyperfine makes MRI accessible to every patient regardless of income or resources.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 317
- Round size: Series A $5M–$78M; Series B $11M–$107M; Series C $12M–$108M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — raised $5M in 2024
Portfolio highlights
- Inari Medical — Inari Medical is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. They are focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. It hasdeveloped two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.The company was founded in 2011 and is headquartered in Irvine, California.
- Gate Bioscience — Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease.
- Dayra Therapeutics — Dayra Therapeutics manufactures peptide based medicines.
We’re (not just) investors.We’re (more than) advisors.We’re (beyond) connectors.Ben Franklin Technology Partners combines the best practices of early stage investing with a higher purpose – to lead the region’s technology community to new heights, creating jobs and transforming lives. For over 30 years, Ben has been the leading seedstage capital provider for the region’s technology sectors, investing over $170 million in more than 1,750 regional technology companies, many of which have gone on to become industry leaders. Ben Franklin has also launched university/industry partnerships that accelerate scientific discoveries to commercialization, and has seeded regional initiatives that strengthen our entrepreneurial community.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Debt Financing, Grant
- Geography: United States
Investor stats
- Total investments: 154
- Round size: Seed $50k–$2M; Grant $5k–$100k; Debt Financing $50k–$975k
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — raised $28M in 2023
Portfolio highlights
- CollX — Snap photos of them and instantly get the current market price. Add them to your collection and track your overall portfolio value.
- Aigensei — Aigensei.ai develops artificial intelligence software and infrastructure tools that support the creation, deployment, and management of AI applications. Its work includes systems for workflow automation, model integration, and operational use of AI across different computing environments and application domains.
- LoanStar Technologies — LoanStar works with lenders to diversify their consumer loan origination strategies. Providing program consulting, market-leading software, and merchant aggregation, LoanStar helps lenders of every size leverage the power of their local brand.LoanStar has developed the MerchantLinQ platform that enables lenders of all sizes to deploy instantpoint-of-sale finance through their local merchants.
SBXi is jointly sponsored by nine firms. We offer equity funding for MIT founders who are working on a term sheet with a lead investor.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Pre-Seed, Seed, Venture - Series Unknown
- Geography: United States, India, Mexico
Investor stats
- Total investments: 197
- Round size: Seed $150k–$7M; Pre-Seed $100k–$1.5M; Venture - Series Unknown $3M–$6.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- LineWise — LineWise, a Y Combinator-backed startup, helps manufacturers maximize production uptime. We use AI to diagnose machine failures, accelerate troubleshooting
- zeroRISC — ZeroRISC operates as a stealth start-up making hardware security foundations transparent and trustworthy.
- Autonomous Cyber — Autonomous Cyber is an artificial intelligence platform for cybersecurity solutions.
Social Starts is a $60M+ venture capital partnership with a uniquely data-driven approach to investing in moment-of-inception and Series A financing rounds.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, Germany
Investor stats
- Total investments: 385
- Round size: Seed $187k–$3.8M; Pre-Seed $100k–$2.3M; Series A $3.3M–$14M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely still investing — raised $8.9M in 2022
Portfolio highlights
- Mae Health — Mae is a maternal health platform that connects expectant mothers with critical resources to drive positive pregnancy outcomes.
- Funnel — Our revolutionary CRM property management software saves both time and money for agents and owners while making leasing more efficient.
- Bark Technologies — Bark's parental controls help you monitor social media, manage screen time, and track location to keep your family safer online.
Catalyst Health Ventures (CHV) is a Boston-based medtech VC firm backing early-stage healthcare technology founders since 2008.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: United States
Investor stats
- Total investments: 49
- Round size: Series A $1.4M–$19M; Series B $2.3M–$33M; Series C $1.3M–$85M
- Lead/follow: 51% lead, 49% follow
- Last fund: May invest from a new fund soon — raised $1.1M in 2020
Portfolio highlights
- Lena Health — Lena is a virtual health assistant that takes care of all tasks to stay on top of the care plan, so you can sit back and focus on the things that matter to you.
- Epitel — Epilog is an unobtrusive wearable seizure detection system that records long-term EEG, anywhere. It gives people living with epilepsy peace of mind with a much-needed tool to better understand and manage their seizures.
- Rejoni — Rejoni uses bio-materials to develop medical devices that improve the outcome of minimally invasive and gynecological surgical procedures.
Silicon Valley Bank is the financial partner of the innovation economy; helping individuals and investors in the innovation ecosystem achieve extraordinary outcomes.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Debt Financing, Series B, Series A
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 708
- Round size: Series A $5M–$27M; Series B $6.5M–$45M; Debt Financing $2M–$115M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Zogenix — Therapeutic Solutions for CNS Disorders and Rare Diseases
- Pharming Group —
- Oxford BioTherapeutics — At Oxford BioTherapeutics, we are dedicated to pioneering the next generation of oncology treatments through targeted therapies, including Antibody-Drug Conjugates (ADC), Immuno-oncology, T-Cell Engagers (TCE), and radiopharmaceuticals.
Cultivation Capital invests in young companies whose ideas have potential to transform the way we live and work.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Series A, Series B
- Geography: United States, Australia, Canada
Investor stats
- Total investments: 310
- Round size: Seed $500k–$4.9M; Series A $1.5M–$15M; Series B $5M–$38M
- Lead/follow: 62% lead, 38% follow
- Last fund: Likely actively investing — fresh fund, raised $6.5M in 2025
Portfolio highlights
- My FLiiP — FLiiP is the gym management software built for commercial gyms in Canada and beyond. It unifies CRM, member management, billing, a branded app, and AI on one platform, the smart way to grow your gym, not just manage it.
- DemandJump — Combining your data with data beyond your four walls DemandJump provides a roadmap of the actions you should take to ensure your marketing drives revenue.
- Force Equals — Force Equals is a Multi Agent AI planning operating system for enterprise software, ai, and business project planning. Manage Idea flow, Portfolio, Define challenges, align your team, collaborate, uncover the hidden requirements, and seamlessly hand off to development, project management or procurement workflows.
The St. Louis Arch Angels is a network of accredited investors who fund early-stage businesses across the St. Louis region.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Seed, Series A
- Geography: United States, Argentina
Investor stats
- Total investments: 76
- Round size: Seed $100k–$3.3M; Series A $1.5M–$8.5M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Peptyde Bio — Peptyde Bio is an Agtech startup positioned to become the go-to supplier of new AMPs.
- SentiAR — SentiAR is digital health, software device company adding a new dimension to clinical practice in interventional procedures. Spun out of Washington University, we are developing the first 3D visualization platform using real-time holography of the patient's anatomy and catheter location, "floating" over the patients, with a goal toprovide the clinician and patient a faster, safer delivery of care.SentiAR’s mission is to transform the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.The visualization is fully controllable “hands-free” by the clinician, providing an ergonomic breakthrough for the treatment and analysis of cardiac arrhythmias within an interventional catheter lab environment. SentiAR is developing the platform for eventual FDA submission.
- Maximum Fidelity Surgical Simulations — The most realistic surgical and trauma simulations for surgeons, forward field operators, medics and medical device development.
Mayo Clinic, a not-for-profit medical group practice, provides medical care, research, and education services. It offers medical care services in various specialties, including diabetes and endocrinology, gastroenterology, gynecology, cancer, neurology and neurosurgery, orthopedics, pulmonology, rheumatology, nephrology, urology, and cardiology andheart surgery.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 116
- Round size: Seed $100k–$5.5M; Series A $3.5M–$40M; Series B $8M–$100M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- SyntaxBio — SyntaxBio develops CRISPR/Cas9-based, genetic programming platform that converts cells into biological computers using DNA-based instructions that read like lines of code. SyntaxBio's platform can program cells without the need for consistent external intervention.
- ElectroKare — Train like the 1%. Electrokare turns wearables into a real-time coaching layer, with electrolyte tracking, ECG integration, and AI-driven performance insights built for elite training.
- Transcripta Bio — Drug discovery at the resolution of biology. Using the power of the transcriptome to discover revolutionary medicines.
Boutique Venture Partners specializes in early-stage investments in healthcare and life sciences
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, France
Investor stats
- Total investments: 37
- Round size: Seed $2.5M–$5.7M; Pre-Seed $1.8M–$2.6M; Series A $4M–$31M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- QMENTA — Our industry-leading neuroimaging cloud-based software works with advanced AI-powered tools to empower researchers, radiologists, and clinical trials.
- Handl Health — Making healthcare price transparency simple, insightful and actionable.
- Ventaris Surgical — Ventaris Surgical is a medical equipment company that provides surgical instruments to specialists.
Medical Device Investor funding in United States at a glance
Stats across 8k deals from 5.6k investors.
Access all 5623 investors in United States Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Investors in United States investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 5623 investors investing in United States Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!